North East and North Cumbria
ICS Formulary
Sub Chapters : 08 Malignant disease and immunosuppression
Back to Chapters
Alkylating drugs
Amsacrine
Anthracyclines and other cytotoxic antibiotics
Anti-androgens
Anti-lymphocyte monoclonal antibodies
Antimetabolites
Antiproliferative immunosuppressants
Arsenic trioxide
BCG bladder instillation
Bevacizumab
Bexarotene
Bortezomib
Breast cancer
Brentuximab vedotin
Cetuximab
Corticosteroids and other immunosuppressants
Cytotoxic drugs
Dacarbazine and Temozolomide
Dimethyl fumarate
Drugs affecting the immune response
Drugs for cytotoxic-induced side-effects
Erlotinib
Fingolimod
Glatiramer acetate
Gonadorelin analogues
Hydroxycarbamide
Interferon Alfa
Interferon beta
Ipilimumab
Lenalidomide, pomalidomide, and thalidomide
Mifamurtide
Mitotane
Natalizumab
Oestrogens
Other antineoplastic drugs
Other immunomodulating drugs
Panitumumab
Pentostatin
Platinum compounds
Porfimer sodium and temoporfin
Procarbazine
Progestogens
Prostate cancer and gonadorelin analogues
Protein kinase inhibitors
Somatostatin analogues
Taxanes
Teriflunomide
Topoisomerase I inhibitors
Trabectedin
Trastuzumab
Tretinoin
Vinca alkaloids and etoposide
Key
Full Site
